Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

03.10.2017

3 AJR Am J Roentgenol
4 Am J Surg
7 Ann Oncol
1 BMC Cancer
1 Breast Cancer Res
7 Breast Cancer Res Treat
2 Cancer
2 Cancer Epidemiol Biomarkers Prev
3 Cancer Res
1 Clin Breast Cancer
2 Clin Cancer Res
3 Eur J Cancer
1 Exp Cell Res
5 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
3 J Natl Cancer Inst
1 J Pathol
1 J Surg Oncol
1 JAMA
1 Lancet Oncol
4 NPJ Breast Cancer
1 Oncology
1 PLoS Comput Biol
4 PLoS Genet
10 PLoS One
1 Radiology
1 Radiother Oncol



    AJR Am J Roentgenol

  1. JENA A, Taneja S, Singh A, Negi P, et al
    Reliability of 18F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study.
    AJR Am J Roentgenol. 2017 Jul 5:1-9. doi: 10.2214/AJR.16.17766.
    >> Share

  2. YOUK JH, Kim SJ, Son EJ, Gweon HM, et al
    Comparison of Visual Assessment of Breast Density in BI-RADS 4th and 5th Editions With Automated Volumetric Measurement.
    AJR Am J Roentgenol. 2017;209:703-708.
    >> Share

  3. NATESAN R, Santiago L, Kalambo M, Martaindale S, et al
    The Impact of Patient Demographics on the Selection of Breast Imaging Centers.
    AJR Am J Roentgenol. 2017 Jun 28:W1-W10. doi: 10.2214/AJR.16.17305.
    >> Share


    Am J Surg

  4. BUCKLEY EJ, Zahnd WE, Rea DJ, Mellinger JD, et al
    Impact of rural-urban status on survival after mastectomy without reconstruction versus mastectomy with reconstruction.
    Am J Surg. 2017;214:645-650.
    >> Share

  5. NURUDEEN S, Guo H, Chun Y, Coopey S, et al
    Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Am J Surg. 2017;214:687-694.
    >> Share

  6. CHAGPAR AB, Horowitz N, Sanft T, Wilson LD, et al
    Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
    Am J Surg. 2017 Sep 19. pii: S0002-9610(17)30420.
    >> Share

  7. CHAGPAR AB
    On baseball and breast cancer.
    Am J Surg. 2017 Sep 20. pii: S0002-9610(17)31086.
    >> Share


    Ann Oncol

  8. MESSINA C, Messina M, Zanardi E
    Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer.
    Ann Oncol. 2017 Sep 18. doi: 10.1093.
    >> Share

  9. FUJII T, Kogawa T, Dong W, Sahin AA, et al
    Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.
    Ann Oncol. 2017;28:2420-2428.
    >> Share

  10. BUTTERBAUGH ST, Patel R, Romond EH, Mathew A, et al
    Trastuzumab use in patients with durable complete response in HER2-amplified metastatic breast cancer: To continue or not to continue.
    Ann Oncol. 2017 Sep 18. doi: 10.1093.
    >> Share

  11. CHUNG JH, Pavlick D, Hartmaier R, Schrock AB, et al
    Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.
    Ann Oncol. 2017 Aug 31. doi: 10.1093.
    >> Share

  12. NITZ UA, Gluz O, Christgen M, Grischke EM, et al
    De-escalation strategies in HER2-positive early breast cancer (EBC): Final analysis of the WSG-ADAPT HER2+/HR- phase II trial: Efficacy, safety, and predictive markers for 12-weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab +/- weekl
    Ann Oncol. 2017 Sep 4. doi: 10.1093.
    >> Share

  13. BERNICHON E, Vallard A, Wang Q, Attignon V, et al
    Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.
    Ann Oncol. 2017 Sep 1. doi: 10.1093.
    >> Share

  14. CHAJES V, Assi N, Biessy C, Ferrari P, et al
    A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.
    Ann Oncol. 2017 Sep 18. doi: 10.1093.
    >> Share


    BMC Cancer

  15. ABHYANKAR N, Hoskins KF, Abern MR, Calip GS, et al
    Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    BMC Cancer. 2017;17:659.
    >> Share


    Breast Cancer Res

  16. PELEKANOU V, Carvajal-Hausdorf DE, Altan M, Wasserman B, et al
    Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.
    Breast Cancer Res. 2017;19:109.
    >> Share


    Breast Cancer Res Treat

  17. LIU YL, Saraf A, Catanese B, Lee SM, et al
    Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
    Breast Cancer Res Treat. 2017 Sep 25. doi: 10.1007/s10549-017-4507.
    >> Share

  18. LUU T, Kim KP, Blanchard S, Anyang B, et al
    Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.
    Breast Cancer Res Treat. 2017 Sep 27. doi: 10.1007/s10549-017-4516.
    >> Share

  19. TSOUTSOU PG, Durham AD, Vozenin MC
    A need for biology-driven personalized radiotherapy in breast cancer.
    Breast Cancer Res Treat. 2017 Sep 27. doi: 10.1007/s10549-017-4522.
    >> Share

  20. GALLARDO A, Lerma E
    Response letter to: Questions about Ki67 staining in luminal breast cancer.
    Breast Cancer Res Treat. 2017 Sep 27. doi: 10.1007/s10549-017-4524.
    >> Share

  21. ALTUNDAG K
    Questions about Ki67 staining in luminal breast cancer.
    Breast Cancer Res Treat. 2017 Sep 27. doi: 10.1007/s10549-017-4515.
    >> Share

  22. CRONIN-FENTON D, Kjaersgaard A, Norgaard M, Amelio J, et al
    Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
    Breast Cancer Res Treat. 2017 Sep 25. doi: 10.1007/s10549-017-4510.
    >> Share

  23. SAYED S, Moloo Z, Wasike R, Bird P, et al
    Ethnicity and breast cancer characteristics in Kenya.
    Breast Cancer Res Treat. 2017 Sep 26. doi: 10.1007/s10549-017-4511.
    >> Share


    Cancer

  24. ARLEO EK, Hendrick RE, Helvie MA, Sickles EA, et al
    Comparison of recommendations for screening mammography using CISNET models.
    Cancer. 2017;123:3673-3680.
    >> Share

  25. CHAOUL A, Milbury K, Spelman A, Basen-Engquist K, et al
    Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.
    Cancer. 2017 Sep 20. doi: 10.1002/cncr.30938.
    >> Share


    Cancer Epidemiol Biomarkers Prev

  26. HIATT RA, Stewart SL, Hoeft KS, Kushi LH, et al
    CHILDHOOD SOCIOECONOMIC POSITION AND PUBERTAL ONSET IN A COHORT OF MULTIETHNIC GIRLS: IMPLICATIONS FOR BREAST CANCER.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 22. pii: cebp.0496.2017.
    >> Share

  27. KABAT GC, Kim MY, Lee JS, Ho GY, et al
    Metabolic obesity phenotypes and risk of breast cancer in postmenopausal women.
    Cancer Epidemiol Biomarkers Prev. 2017 Sep 22. pii: cebp.0495.2017.
    >> Share


    Cancer Res

  28. CHEN L, Chubak J, Boudreau DM, Barlow WE, et al
    Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: A SEER-Medicare analysis.
    Cancer Res. 2017 Sep 21. pii: canres.0687.2017.
    >> Share

  29. YANG A, Qin S, Schulte BA, Ethier SP, et al
    MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer.
    Cancer Res. 2017 Sep 26. pii: canres.3452.2016.
    >> Share

  30. TEO ZL, Versaci S, Dushyanthen S, Caramia F, et al
    Combined CDK4/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple negative breast cancer.
    Cancer Res. 2017 Sep 25. pii: canres.2210.2017.
    >> Share


    Clin Breast Cancer

  31. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    >> Share


    Clin Cancer Res

  32. ZHANG Y, Schroeder BE, Jerevall PL, Ly A, et al
    A novel Breast Cancer Index for prediction of distant recurrence in HR+ early stage breast cancer with 1 to 3 positive nodes.
    Clin Cancer Res. 2017 Sep 22. pii: clincanres.1688.2017.
    >> Share

  33. DOOSTAN I, Karakas C, Kohansal M, Low KH, et al
    Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.
    Clin Cancer Res. 2017 Sep 25. pii: clincanres.1544.2017.
    >> Share


    Eur J Cancer

  34. BIGANZOLI L, Marotti L, Hart CD, Cataliotti L, et al
    Quality indicators in breast cancer care: An update from the EUSOMA working group.
    Eur J Cancer. 2017;86:59-81.
    >> Share

  35. GUERIN M, Rezai K, Isambert N, Campone M, et al
    PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
    Eur J Cancer. 2017;86:28-36.
    >> Share

  36. PIVOT X, Verma S, Fallowfield L, Muller V, et al
    Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study.
    Eur J Cancer. 2017;86:82-90.
    >> Share


    Exp Cell Res

  37. CASCIONE M, De Matteis V, Toma CC, Pellegrino P, et al
    Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.
    Exp Cell Res. 2017 Sep 19. pii: S0014-4827(17)30500.
    >> Share


    Int J Cancer

  38. GUO S, Jing Y, Burcus NI, Lassiter BP, et al
    Nano-Pulse Stimulation Induces Potent Immune Responses, Eradicating Local Breast Cancer while Reducing Distant Metastases.
    Int J Cancer. 2017 Sep 25. doi: 10.1002/ijc.31071.
    >> Share

  39. THAPA B, Bahadur Kc R, Uludag H
    Novel Targets for Sensitizing Breast Cancer Cells to TRAIL-Induced Apoptosis with siRNA Delivery.
    Int J Cancer. 2017 Sep 27. doi: 10.1002/ijc.31079.
    >> Share

  40. WILKE CM, Hess J, Klymenko SV, Chumak VV, et al
    Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer.
    Int J Cancer. 2017 Sep 25. doi: 10.1002/ijc.31072.
    >> Share

  41. KORCH C, Hall EM, Dirks WG, Ewing M, et al
    Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31067.
    >> Share

  42. KIMBUNG S, Markholm I, Bjohle J, Lekberg T, et al
    Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: results from the phase 2 PROMIX trial.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31070.
    >> Share


    Int J Radiat Oncol Biol Phys

  43. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
    Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:459-467.
    >> Share

  44. VOGEL J, Lin L, Litzky LA, Berman AT, et al
    Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Int J Radiat Oncol Biol Phys. 2017;99:427-433.
    >> Share


    J Clin Oncol

  45. WU JW, Azoulay L, Majdan A, Boivin JF, et al
    Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes.
    J Clin Oncol. 2017 Sep 27:JCO2017734491. doi: 10.1200/JCO.2017.73.4491.
    >> Share


    J Natl Cancer Inst

  46. BANDOS H, Melnikow J, Rivera DR, Swain SM, et al
    Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
    J Natl Cancer Inst. 2018;110.
    >> Share

  47. RIVERA DR, Ganz PA, Weyrich MS, Bandos H, et al
    Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    >> Share

  48. JOHNSON SB, Park HS, Gross CP, Yu JB, et al
    Use of Alternative Medicine for Cancer and Its Impact on Survival.
    J Natl Cancer Inst. 2018;110.
    >> Share


    J Pathol

  49. CHEN H, Liu D, Guo L, Cheng X, et al
    Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating beta-adrenergic signaling.
    J Pathol. 2017 Sep 22. doi: 10.1002/path.4988.
    >> Share


    J Surg Oncol

  50. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    >> Share


    JAMA

  51. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    >> Share


    Lancet Oncol

  52. GOURD E
    Pyrotinib shows activity in metastatic breast cancer.
    Lancet Oncol. 2017 Sep 21. pii: S1470-2045(17)30755.
    >> Share


    NPJ Breast Cancer

  53. WOLF DM, Yau C, Sanil A, Glas A, et al
    DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.
    NPJ Breast Cancer. 2017;3:31.
    >> Share

  54. ROBINSON BN, Newman AF, Tefera E, Herbolsheimer P, et al
    Video intervention increases participation of black breast cancer patients in therapeutic trials.
    NPJ Breast Cancer. 2017;3:36.
    >> Share

  55. ESSERMAN LJ
    The WISDOM Study: breaking the deadlock in the breast cancer screening debate.
    NPJ Breast Cancer. 2017;3:34.
    >> Share

  56. LIGIBEL JA, Barry WT, Alfano C, Hershman DL, et al
    Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.
    NPJ Breast Cancer. 2017;3:37.
    >> Share


    Oncology

  57. GAL O, Ishai Y, Sulkes A, Shochat T, et al
    Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome.
    Oncology. 2017 Sep 27. doi: 10.1159/000480087.
    >> Share


    PLoS Comput Biol

  58. DUMEAUX V, Fjukstad B, Fjosne HE, Frantzen JO, et al
    Interactions between the tumor and the blood systemic response of breast cancer patients.
    PLoS Comput Biol. 2017;13:e1005680.
    >> Share


    PLoS Genet

  59. GAO G, Pierce BL, Olopade OI, Im HK, et al
    Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
    PLoS Genet. 2017;13:e1006727.
    >> Share

  60. MECHANIC LE, Lindstrom S, Daily KM, Sieberts SK, et al
    Up For A Challenge (U4C): Stimulating innovation in breast cancer genetic epidemiology.
    PLoS Genet. 2017;13:e1006945.
    >> Share

  61. LIU Y, Walavalkar NM, Dozmorov MG, Rich SS, et al
    Identification of breast cancer associated variants that modulate transcription factor binding.
    PLoS Genet. 2017;13:e1006761.
    >> Share

  62. WANG W, Xu ZZ, Costanzo M, Boone C, et al
    Pathway-based discovery of genetic interactions in breast cancer.
    PLoS Genet. 2017;13:e1006973.
    >> Share


    PLoS One

  63. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  64. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    >> Share

  65. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    >> Share

  66. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    >> Share

  67. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    >> Share

  68. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    >> Share

  69. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    >> Share

  70. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    >> Share

  71. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    >> Share

  72. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    >> Share


    Radiology

  73. SALEM K, Kumar M, Powers GL, Jeffery JJ, et al
    18F-16alpha-17beta-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.
    Radiology. 2017 Sep 25:162956. doi: 10.1148/radiol.2017162956.
    >> Share


    Radiother Oncol

  74. TROVO M, Furlan C, Polesel J, Fiorica F, et al
    Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
    Radiother Oncol. 2017 Sep 21. pii: S0167-8140(17)32556.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016